A Calgary-based biotech company is turning heads on Tuesday after it was announced that a recent study showed its lead drug candidate MB-204 demonstrated a 400% increase in the...

To read the full story on AllPennyStocks.com, click here.

Marvel Biosciences (TSXV:MRVL)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Marvel Biosciences Charts.
Marvel Biosciences (TSXV:MRVL)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Marvel Biosciences Charts.